COVAX is the vaccines pillar of the Access to COVID-19 Tools (ACT) AcceleratorThe ACT Accelerator is a ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines.
Who is Co-leading the COVID-19 Covax vaccine?
Gavi is co-leading COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator.
What is COVAX in the context of COVID-19?
COVAX is the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. The ACT Accelerator is a ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines.
What is a COVID-19 variant of interest?
A variant with specific genetic markers that have been associated with changes to receptor binding, reduced neutralization by antibodies generated against previous infection or vaccination, reduced efficacy of treatments, potential diagnostic impact, or predicted increase in transmissibility or disease severity.
Who developed the Moderna COVID-19 vaccine?
The vaccine has been developed by Moderna, in Cambridge, Massachusetts, and funded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the US National Institutes of Health.
What organizations are being used to deliver COVID-19 vaccines?
With one exception, distribution and delivery of COVID-19 vaccines and other routine vaccines are accomplished through a Federal delivery system; Pfizer distributes and delivers doses of its COVID-19 vaccine through its own delivery system.
